12th Annual Crohn’s and Colitis Awareness Week
Welcome to the 12th Annual Crohn’s and Colitis Awareness Week, a significant event observed from December 1-7. This designated week serves as a poignant reminder of the unique challenges faced by the 1.25 million individuals grappling with ulcerative colitis and the 1.01 million contending with Crohn’s disease. Termed as “sister” diseases, these conditions share certain similarities but distinctly impact various areas of the digestive system. The symptoms, not only unique to each disease but also varying among individuals, the complexity of these autoimmune disorders. Adding to the complexity, Irritable Bowel Syndrome (IBS) contributes to the broader spectrum, affecting around 10 million people globally. The profound impact of these conditions extends beyond physical health, affecting the quality of life and day-to-day experiences of those affected. Anxiety, depression, and CPTSD often accompany the physical challenges, emphasizing the multi-faceted nature of these health issues.
A Closer Look at Symptoms
At the core of Crohn’s and colitis lies the challenge of autoimmune diseases, where the body’s defense mechanism turns against itself. The antibodies, designed to safeguard against viruses and toxins, can become misguided or confused. In certain individuals, these antibodies, or the immune system as a whole, struggle to distinguish between virus cells and healthy cells. This internal confusion results in autoimmune diseases such as Crohn’s and colitis. The body literally attacks its self.
Symptoms associated with these conditions encompass a range of manifestations, including persistent fatigue, frequent fevers, unrelenting malaise, joint pain and swelling, skin sensitivity, and swollen glands. The intricate interplay of these symptoms underscores the intricate nature of autoimmune disorders.
What is Crohn’s Disease?
According to the Mayo Clinic, Crohn’s disease stands as a formidable inflammatory bowel disease characterized by chronic inflammation spanning the entire digestive system, from the mouth to the anus. While its primary impact is felt in the small bowel, the disease can also manifest in scattered or “patched” areas, adding an additional layer of complexity. Varying in severity, individuals may experience periods of remission, providing temporary relief.
Symptoms associated with Crohn’s disease present a diverse array of challenges, including intense cramps, severe fatigue, persistent fever, loss of appetite, weight loss, episodes of watery and bloody diarrhea, constipation, eye swelling, and joint pain. The wide variety and intensity of these symptoms contribute to the complexity of managing Crohn’s disease.
What is Ulcerative Colitis?
On the other hand, ulcerative colitis, another form of bowel disease, causes inflammation in the large intestine, resulting in bleeding ulcers on the inner lining of the intestines. The manifestations of this condition add a layer of complexity to the already intricate landscape of autoimmune disorders.
Symptoms associated with ulcerative colitis include severe abdominal pain, frequent episodes of diarrhea with blood and mucus, persistent fever, weight loss, loss of appetite, and anemia. These symptoms, when combined, underscore the profound impact of ulcerative colitis on an individual’s overall well-being.
Treatments
Both Crohn’s and colitis necessitate comprehensive treatment approaches, often involving the use of intense drugs referred to as “immunosuppressants.” These medications play a pivotal role in managing symptoms by suppressing the immune system, recognizing that these diseases emerge from the immune system’s misguided attack on itself.
Among the commonly prescribed immunosuppressive medications is “prednisone” or “steroids.” While effective in mitigating symptoms, this miracle drug is not without its challenges. Side effects, ranging from weight gain in the face (“moon face”) to insomnia, restlessness, profuse sweating, mood changes, vomiting, and alterations in eyesight, present a complex landscape of considerations for individuals navigating their
Important Information
For those dealing with these conditions or supporting loved ones on this challenging journey, conducting in-depth research on Crohn’s, colitis, and IBS is highly advisable. These illnesses, often termed “invisible,” pose unique challenges as individuals may outwardly appear fine while coping with significant internal struggles.
It is crucial to emphasize that cannabis is not positioned as a cure for these conditions. Before considering cannabis consumption, consulting with a healthcare professional is essential. The discussion around cannabis here is for educational, informative, and entertainment purposes only. Individuals with severe Crohn’s or colitis should not solely rely on cannabis, recognizing potential interactions with medications.
Cannabis, when considered, may play a role for those with mild to moderate Crohn’s or colitis, especially during remission, offering relief for symptoms such as slight nausea and insomnia. However, in severe cases, cannabis may not singularly induce or contribute to full remission. Such cases necessitate Western medicine interventions and, in some instances, surgical procedures.
Research has shown that specific terpenes have the potential to alleviate mild to moderate symptoms. For example, the terpene Linalool, found abundantly in lavender, jasmine, and other aromatic plants, has a floral scent and possesses sedative and anxiolytic properties. This makes it beneficial for reducing anxiety, insomnia, and restlessness.
Another noteworthy terpene is Beta-Caryophyllene, present in black pepper, cloves, and certain cannabis strains. Beta-Caryophyllene exhibits anti-inflammatory and analgesic effects, potentially aiding in managing physical discomfort, including breast tenderness and abdominal pain. Additionally, terpenes like pinene, myrcene, and limonene have been identified for their ability to reduce feelings of nausea and promote relaxation in the digestive system. These findings highlight the potential therapeutic effects of terpenes, offering a natural approach to symptom management.
How to Support Someone with Crohn’s, Colitis, or IBS: A Call for Empathy and Understanding
Supporting someone with Crohn’s, colitis, or IBS requires a nuanced approach rooted in empathy and understanding. Acknowledge the unpredictability of their conditions, understanding that plans may be canceled or alterations required. Refrain from judgment, creating an environment where individuals feel supported rather than burdened by societal expectations.
Regular check-ins on their mental and emotional well-being are paramount. Many people dealing with autoimmune diseases experience isolation and emotional struggles. Providing a supportive presence and a listening ear can make a significant difference in their journey.
If an individual incorporates cannabis into their treatment regimen, approach the topic with an open mind. Inquire about their experiences to gain a better understanding of the medicinal aspects of cannabis in their unique context.
Most importantly, let them know that you care. Acts of kindness, whether big or small, can have a profound impact on individuals navigating the complexities of autoimmune disorders. By fostering an environment of understanding and support, we contribute to a community that uplifts and empowers those facing these health challenges.
Disclaimer
The information provided here is for educational and informational purposes only. It is not intended to condone or promote the use of cannabis as a cure for any medical condition. The content is meant to offer insights into the potential therapeutic effects of certain terpenes and their association with symptom management.
Before considering the consumption of cannabis or any related products, it is strongly advised to consult with a qualified healthcare professional. Individual responses to cannabis can vary, and its interaction with existing medical conditions and medications should be thoroughly assessed by a medical professional.
The author of this content does not endorse or encourage the use of cannabis for any specific purpose, and the information presented should not be considered as medical advice. Any decisions regarding the use of cannabis or related products should be made in consultation with a licensed healthcare provider who can provide personalized guidance based on an individual’s health status and medical history.
Thank you for reading!
-Blurry 🙂
